Several bodies of evidence indicate that DUBs regulate the stability of PD-L1 protein and are linked to various cancer progressions, including breast cancer, hepatocellular carcinoma, gastric cancer, bladder cancer, ovarian cancer, and pancreatic cancer 36. Here, CD274 is linked to familial pancreatic carcinoma.